In continuation of its commitment to strengthen scientific knowledge and promote advanced disease control strategies in the poultry sector, Stallen South Asia Pvt. Ltd. organized a highly informative technical seminar in Pune, themed “Comprehensive Flock Protection: Addressing Mycoplasmosis, Infectious Bronchitis & Salmonellosis.”
The event witnessed the participation of over 80 progressive poultry farmers, consultants, and technical experts, who gathered to explore emerging disease trends, modern vaccine technologies, and integrated flock protection programs aimed at improving productivity and profitability.
The seminar opened with a warm welcome by Dr. Sanjay Singhal, Chief Operating Officer, Stallen South Asia Pvt. Ltd., who shared the inspiring journey of Stallen — from its modest beginnings in the late 1990s as a pharmaceutical company to its current evolution into a biotechnology-focused organization. Dr. Singhal emphasized how Stallen has constantly adapted to the changing needs of the poultry industry, shifting from conventional drugs to next-generation biologicals and vaccines that align with global trends in responsible poultry production. He also spoke about the company’s product range, collaborations, and upcoming innovations, reaffirming Stallen’s vision to offer science-driven solutions that ensure healthier flocks and sustainable farming.
The technical keynote address was delivered by Dr. Jayaraman K, a veteran poultry health expert with more than three decades of experience. In his session, Dr. Jayaraman provided an in-depth overview of the disease triad — Mycoplasmosis, Infectious Bronchitis, and Salmonellosis — explaining how these infections interact, compromise respiratory health, and affect egg production, hatchability, and overall flock performance. He discussed diagnostic approaches, field management practices, and the role of vaccination in breaking the infection cycle. His presentation was both insightful and practical, blending scientific clarity with field relevance, which kept the audience thoroughly engaged. The interactive Q&A session that followed helped participants gain clarity on key aspects of disease prevention and control.
The final session was conducted by Dr. Kishor Gedam, Product Manager, Stallen South Asia Pvt. Ltd., who presented Stallen’s comprehensive vaccine portfolio imported directly from FATRO, Italy. He elaborated on flagship products such as MYC-VAC — a Mycoplasma gallisepticum killed vaccine, MS-VAC — a Mycoplasma synoviae killed vaccine, and IB-OLVAC, a killed vaccine offering protection against Infectious Bronchitis and Newcastle Disease. Dr. Gedam also introduced BIOVAC SGP695, an innovative patented live vaccine for Salmonella gallinarum/pullorum, and enteritidis infections, which is notably the first water-administered Salmonella vaccine available in the Indian market. Together, these products represent Stallen’s holistic approach to flock protection — offering reliable, science-backed, and field-tested vaccination options to Indian poultry producers.
The event concluded with a heartfelt vote of thanks by Mr. Macchindra Shinde, Regional Sales Manager (West), who appreciated the enthusiastic participation of the attendees and the valuable insights shared by the speakers. A networking dinner followed, allowing farmers, consultants, and experts to interact informally and exchange ideas for improving poultry health and productivity. With this successful seminar, Stallen South Asia once again reaffirmed its dedication to knowledge sharing, innovation, and farmer partnership. The company continues to take confident strides toward building a healthier, more productive poultry industry — one that thrives on science, sustainability, and shared success.